Published in Immunology on November 01, 1968
Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96
Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
The cellular origin of the lymphochte trap. Immunology (1974) 1.27
The effect of heterologous anti-lymphocyte serum on lymphocytes of thymus and marrow origin. J Exp Med (1970) 1.04
Recirculating lymphocytes in the mouse thymus are part of the relatively cortisone resistant cell population. Clin Exp Immunol (1972) 0.86
Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the host. Clin Exp Immunol (1968) 0.86
Tolerance of rat skin grafts in adult mice. Proc Natl Acad Sci U S A (1969) 0.86
Effect of antilymphocyte serum on macrophage activity. Clin Exp Immunol (1970) 0.85
In vitro spleen leucocyte migration and phytohaemagglutinin-stimulated lymphocyte transformation of immunosuppressed mice cells. I. Cells from mice treated by thymectomy and/or rabbit anti-mouse lymphocyte serum. Clin Exp Immunol (1974) 0.81
Hepatic homing of labelled lymphocytes in man. Br Med J (1972) 0.78
Antigen-initiated B-lymphocyte differentiation. VII. Quantification of AFC progenitor levels in adoptive and culture responses to NIP-POL antigen. Immunology (1975) 0.77
Mode of recovery from the effects of heterologous anti-lymphocyte serum. II. Recovery of the cells involved in antibody production. Immunology (1972) 0.75
Differential requirement for B-memory and T-memory cells in adoptive antibody formation in mouse bone marrow. Immunology (1982) 0.75
Depletion of lymphoid tissues by tilorone. Ultrastructure and synergistic interaction with antilymphocyte serum. Am J Pathol (1983) 0.75
Thymus-dependent areas in the lymphoid organs of neonatally thymectomized mice. J Exp Med (1966) 8.61
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type. J Exp Med (1961) 6.05
Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol (1966) 5.59
A HISTOLOGICAL AND AUTORADIOGRAPHIC STUDY OF LYMPH NODES DURING THE DEVELOPMENT OF CONTACT SENSITIVITY IN THE GUINEA-PIG. Br J Exp Pathol (1965) 4.97
Central and peripheral effects of anti-lymphocyte sera. Lancet (1967) 3.76
EFFECT OF LYMPHOCYTE DEPLETION BY THORACIC DUCT FISTULA AND ADMINISTRATION OF ANTILYMPHOCYTIC SERUM ON THE SURVIVAL OF SKIN HOMOGRAFTS IN RATS. Nature (1963) 3.65
Radioautographic studies of small lymphocytes in the thoracic duct of the rat. Acta Haematol (1962) 3.50
Further experiments on the action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1967) 2.31
Distribution of allogeneic 51Cr-labelled lymph node cells in mice. Transplantation (1966) 2.12
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Activity of lymphoid tissues from antilymphocyte-serum-treated mice. Lancet (1967) 1.66
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Immunological reactivity of lymphoid cells after treatment with anti-lymphocytic serum. Nature (1967) 1.30
[Preparation and effect of heterologous anti-dog lymphocyte serums]. Z Gesamte Exp Med (1967) 0.87
The distribution of 51Cr-labeled lymphocytes into antigen-stimulated mice. Lymphocyte trapping. J Exp Med (1971) 2.60
Immuno-regulatory role of spleen localizing thymocytes. J Immunol (1974) 2.27
The effect of localized injection of adjuvant material on the draining lymph node. II. Circulating lymphocytes. Immunology (1970) 2.19
Segregation of lymphocyte populations through differential migration. Nature (1969) 2.09
The effect of localized injection of adjuvant material on the draining lymph node. I. Histology. Immunology (1970) 2.00
Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96
Rejection of skin allografts by radiation chimaeras: selective gene action in the specification of cell surface structure. Nature (1970) 1.95
Immunologic dysfunction in heroin addicts. Arch Intern Med (1974) 1.77
The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives. Clin Exp Immunol (1970) 1.76
The distribution of chromium 51-labelled lymphoid cells in the mouse. A survey of anatomical compartments. Cell Immunol (1970) 1.67
Antigenicity in mice of antilymphocyte gamma-globulin. Nature (1967) 1.67
Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61
Immunologic reactivity in rheumatoid arthritis. Response to mitogens. Arthritis Rheum (1974) 1.52
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence. J Immunol (1972) 1.48
Experimental immune synovitis in the rabbit. Relative roles of cell mediated and humoral immunity. Arthritis Rheum (1975) 1.46
Architectural organization in the interphase nucleus of the protozoan Trypanosoma brucei: location of telomeres and mini-chromosomes. EMBO J (1990) 1.44
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res (1991) 1.40
Survival of skin heterografts under treatment with antilymphocytic serum. Lancet (1968) 1.39
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
The use of subcellular fractions to raise anti-lymphocytic serum. Immunology (1968) 1.36
Quantitative studies on tissue transplantation immunity. IX. Induction of tolerance with antilymphocytic serum. Proc R Soc Lond B Biol Sci (1969) 1.33
Changes in lymphoid populations of ageing CBA and NZB mice. Clin Exp Immunol (1971) 1.31
The cellular origin of the lymphochte trap. Immunology (1974) 1.27
Effects of lymphoid depletion on the distribution of 51Cr-labeled lymph node cells in mice. Transplantation (1971) 1.23
Homing of specifically sensitized lymphocytes to allografts of skin. Cell Immunol (1972) 1.20
Distribution of labeled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis. J Exp Med (1972) 1.14
The mechanism of action of anti-lymphocyte serum. Studies of antibody eluate. J Exp Med (1969) 1.13
Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance. Cancer Res (1987) 1.11
Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells. Cancer Res (1989) 1.09
Limb and joint transplantation. A review of research and clinical experience. Clin Orthop Relat Res (1974) 1.07
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07
Chemotherapy for advanced sarcoma: therapeutic decisions and modalities. Semin Oncol (1997) 1.06
Induction of tolerance with antilymphocytic serum. Transplant Proc (1969) 1.06
Selective suppression of cellular immunity by antilymphocyte serum. Transplantation (1968) 1.06
Antigenic change and cell maturation in murine thymocytes. Cell Immunol (1970) 1.06
Immunosuppressive effects of heterologous antilymphocyte serum in monkeys. Lancet (1970) 1.04
Isolation and characterization of an anthracycline-resistant human leukemic cell line. Cancer Res (1985) 1.03
Rejection of skin allografts by irradiation chimeras: evidence for skin-specific transplantation barrier. Transplant Proc (1971) 1.03
Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells. Cancer Res (1989) 1.02
The effect of histocompatibility antigens on lymphocyte migration in the mouse. Immunology (1972) 1.02
The effects of ALG on the murine immune response to sheep erythrocytes. Immunology (1972) 1.01
Foetal antigens and cancer. Nature (1973) 1.00
A functional and morphologic study of intracranial thyroid allografts in the dog. Surg Gynecol Obstet (1967) 0.99
A serological method for detecting the surface antigens of epidermal cells. Transplantation (1971) 0.99
Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response. Clin Exp Immunol (1975) 0.98
Assessment of potential exposure to antineoplastic agents in the health care setting. Prev Med (1984) 0.97
Immunoregulation by spleen-seeking thymocytes. II. Role in the response to sheep erythrocytes. Cell Immunol (1974) 0.97
Abrogation of lymphocyte trapping by ascitic tumours. Nature (1973) 0.96
Lymphocyte trapping in tolerant mice. Nat New Biol (1971) 0.94
Hematologic and immunologic aspects of parabiosis. Mt Sinai J Med (1976) 0.94
Study of lymphoid cells from inflamed synovial membranes. Ann Rheum Dis (1975) 0.93
The LDH virus: an interfering biological contaminant. Science (1978) 0.93
Kinetic studies of macrophages. I. Distributional characteristics of radiolabeled peritoneal cells. J Reticuloendothel Soc (1971) 0.92
Mode of action of antilymphocyte serum. Fed Proc (1970) 0.92
Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors. Oncogene (2006) 0.91
Surgical reconstruction of the skeleton following segmental resection for bone tumors. J Bone Joint Surg Am (1965) 0.91
Letter: Lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1975) 0.91
Immunologic diagnosis and monitoring of human acute leukemias: a review. Am J Pathol (1981) 0.90
Immunotherapy with dinitrochlorobenzene (DNCB) for recurrent squamous cell tumor of conjunctiva. Trans Am Ophthalmol Soc (1976) 0.89
The stimulation of lymphocytes by chondrocytes in mixed cultures. Clin Exp Immunol (1976) 0.89
Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro. Clin Exp Immunol (1975) 0.89
Some observations on the in vitro reactivity of lymphoid subpopulations. Cell Immunol (1974) 0.89
Specific impairment of humoral and cellular allograft immunity after splenic allotransplantation in rats. Transplant Proc (1977) 0.88
Use of subcellular lymphocyte fractions to raise anti- lymphocyte serum. Fed Proc (1970) 0.88
Specificity of heteroantisera to human acute leukemia-associated antigens. J Clin Invest (1974) 0.87
The reactivity of murine lymphocytes to epidermal cells. Immunology (1972) 0.87
Response of mice to xenografts of skin. Transplant Proc (1970) 0.87
Immunologic aberrations in the Di Guglielmo syndrome. Blood (1966) 0.87
Transplantation of the canine hind limb. Surgical technique and methods of immunosuppression for allotransplantation. A preliminary report. J Bone Joint Surg Am (1971) 0.87
Immunotherapy of human cancer. Prog Allergy (1973) 0.87
Induction of granulomas in mice by inoculation of tissue homogenates from patients with inflammatory bowel disease and sarcoidosis. Ann N Y Acad Sci (1976) 0.86
Tolerance of rat skin grafts in adult mice. Proc Natl Acad Sci U S A (1969) 0.86
Isolation and partial characterization of radioiodinated myeloblastic leukemia-associated cell surface glycoprotein antigen. Cancer Res (1978) 0.85
Transmission of ileitis and sarcoid granulomas to mice. Trans Assoc Am Physicians (1974) 0.85
The effect of heterologous antilymphocyte serum (ALS) on the humoral antibody response to Salmonella typhi "H" antigen and bovine serum albumin. J Immunol (1970) 0.85
Delayed cutaneous hypersensitivity in leukaemic patients to autologous blast cells. Br J Haematol (1974) 0.84
Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels. Clin Exp Immunol (1975) 0.84
Cyclophosphamide-induced immunologic tolerance to skin homografts. Surg Forum (1971) 0.84
Characterization of compounds shed from the surface of human leukemic myeloblasts in vitro. Blood (1982) 0.84
Effects of cortisol and antilymphocyte serum on lymphoid populations. Ciba Found Study Group (1970) 0.84
Effects of heterologous antilymphocyte serum on lymphoid cells labeled with 5-iodo-2-deoxyuridine-125-I. Fed Proc (1970) 0.84
Prolongation of skin homograft survival by mouse-anti-mouse thymocyte isoantiserum. Transplant Proc (1969) 0.84
Editorial: A transmissible agent in Crohn's disease? New pursuit of an old concept. N Engl J Med (1975) 0.84
On the mode of action of thymosin. Cell Immunol (1973) 0.84
Serologic characterization of a monkey antiserum to human leukemic myeloblasts. Blood (1980) 0.83
Peripheral blood lymphocyte subpopulations in sarcoidosis. Cell Immunol (1975) 0.83
Masking of neutrophil surface lectin-binding sites in chronic myelogenous leukemia (CML). Blood (1980) 0.83
Effects of pyrimidine antagonists on sialic acid regeneration in HL-60 cells. Cancer Res (1985) 0.83
Some observations on bone graft technology. Clin Orthop Relat Res (1985) 0.83
Antigen-induced immunological tolerance in man to equine anti-human-thymocyte gamma-globulin. Lancet (1969) 0.82
Kinetic studies of macrophages. IV. Effect of irradiation. J Reticuloendothel Soc (1973) 0.82
On the mechanism of action of adjuvants. Immunology (1978) 0.82
Mechanisms and kinetics of cyclophosphamide-induced specific tolerance to skin allografts in mice. Transplant Proc (1973) 0.82
In vivo effects of concanavalin A. I. Immunosuppressive effects. Transplantation (1972) 0.81